ZA200709011B - Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer - Google Patents
Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancerInfo
- Publication number
- ZA200709011B ZA200709011B ZA200709011A ZA200709011A ZA200709011B ZA 200709011 B ZA200709011 B ZA 200709011B ZA 200709011 A ZA200709011 A ZA 200709011A ZA 200709011 A ZA200709011 A ZA 200709011A ZA 200709011 B ZA200709011 B ZA 200709011B
- Authority
- ZA
- South Africa
- Prior art keywords
- cancer
- treatment
- nucleoside compounds
- phosphoramidate derivatives
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0505781.5A GB0505781D0 (en) | 2005-03-21 | 2005-03-21 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200709011B true ZA200709011B (en) | 2009-01-28 |
Family
ID=34531603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200709011A ZA200709011B (en) | 2005-03-21 | 2006-03-16 | Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer |
Country Status (20)
Country | Link |
---|---|
US (1) | US8263575B2 (da) |
EP (1) | EP1866324B1 (da) |
JP (2) | JP5345381B2 (da) |
CN (2) | CN101175763A (da) |
AT (1) | ATE471334T1 (da) |
AU (1) | AU2006226182C1 (da) |
BR (1) | BRPI0609704B8 (da) |
CA (1) | CA2602324C (da) |
CY (1) | CY1111538T1 (da) |
DE (1) | DE602006014949D1 (da) |
DK (1) | DK1866324T3 (da) |
ES (1) | ES2348741T3 (da) |
GB (1) | GB0505781D0 (da) |
IL (1) | IL186104A (da) |
MX (1) | MX2007011666A (da) |
PL (1) | PL1866324T3 (da) |
PT (1) | PT1866324E (da) |
SI (1) | SI1866324T1 (da) |
WO (1) | WO2006100439A1 (da) |
ZA (1) | ZA200709011B (da) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0623493D0 (en) * | 2006-11-24 | 2007-01-03 | Univ Cardiff | Chemical compounds |
AU2012216500B2 (en) * | 2006-11-24 | 2013-06-20 | Katholieke Universiteit Leuven | Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis C virus |
US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
SG172359A1 (en) | 2008-12-23 | 2011-07-28 | Pharmasset Inc | Nucleoside phosphoramidates |
CL2009002208A1 (es) | 2008-12-23 | 2010-10-29 | Gilead Pharmasset Llc | Un compuesto (2s)-2-((((2r,3r,4r,5r)-5-(2-amino-6-etoxi-9h-purin-9-il)-4-fluoro-3-hidroxi-4-metiltetrahidrofuran-2-il)metoxi)(hidroxi)fosforilamino)propanoico, inhibidores de la replicacion de arn viral; composicion farmaceutica; y su uso en el tratamiento de infeccion por hepatitis c, virus del nilo occidental, entre otras. |
KR20110104074A (ko) | 2008-12-23 | 2011-09-21 | 파마셋 인코포레이티드 | 퓨린 뉴클레오시드의 합성 |
SG172921A1 (en) | 2009-01-09 | 2011-08-29 | Univ Cardiff | Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections |
KR101715981B1 (ko) | 2010-03-31 | 2017-03-13 | 길리애드 파마셋 엘엘씨 | 뉴클레오사이드 포스포르아미데이트 |
GB201016855D0 (en) * | 2010-10-06 | 2010-11-17 | Nucana Biomed Ltd | Chemical compounds |
US9351989B2 (en) | 2010-12-29 | 2016-05-31 | Inhibitex, Inc. | Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections |
CN103403014B (zh) * | 2011-01-03 | 2016-07-06 | 河南美泰宝生物制药有限公司 | O-(经取代的苯甲基)氨基磷酸酯化合物及其治疗用途 |
LT3447061T (lt) | 2011-03-01 | 2022-01-25 | NuCana plc | Farmacinė vaisto forma, apimanti 5-fluor-2'-deoksiuridinofosforamidato darinį, skirtą naudoti vėžio gydymui |
WO2012125900A1 (en) | 2011-03-16 | 2012-09-20 | Enanta Pharmaceuticals, Inc. | 2'-allene-substituted nucleoside derivatives |
EA028871B1 (ru) | 2012-11-16 | 2018-01-31 | Юниверсити Колледж Кардифф Консалтантс Лимитед | Способ получения химических соединений |
WO2014197578A1 (en) | 2013-06-05 | 2014-12-11 | Idenix Pharmaceuticals, Inc. | 1',4'-thio nucleosides for the treatment of hcv |
WO2015081133A2 (en) * | 2013-11-27 | 2015-06-04 | Idenix Pharmaceuticals, Inc. | Nucleotides for the treatment of liver cancer |
US20170101431A1 (en) * | 2014-05-28 | 2017-04-13 | Idenix Pharmaceuticals Llc | Nucleoside derivatives for the treatment of cancer |
JP2017516779A (ja) * | 2014-05-28 | 2017-06-22 | アイデニクス・ファーマシューティカルズ・エルエルシー | 癌治療のためのヌクレオシド誘導体 |
CA2962373C (en) | 2014-11-28 | 2023-04-25 | Nucana Biomed Limited | 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds |
AU2016229966B2 (en) | 2015-03-06 | 2018-09-27 | Atea Pharmaceuticals, Inc. | Beta-D-2'-deoxy-2'alpha-fluoro-2'-beta-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment |
AU2016355429B2 (en) | 2015-11-16 | 2021-05-06 | Cerecor, Inc. | Nucleic acid prodrugs |
GB201522764D0 (en) * | 2015-12-23 | 2016-02-03 | Nucana Biomed Ltd | Formulations of phosphate derivatives |
GB201609600D0 (en) * | 2016-06-01 | 2016-07-13 | Nucuna Biomed Ltd | Cancer treatments |
GB201609601D0 (en) | 2016-06-01 | 2016-07-13 | Nucana Biomed Ltd | Phosphoramidate compounds |
GB201609602D0 (en) * | 2016-06-01 | 2016-07-13 | Nucuna Biomed Ltd | Chemical compounds |
US10711029B2 (en) | 2016-07-14 | 2020-07-14 | Atea Pharmaceuticals, Inc. | Beta-d-2′-deoxy-2′-alpha-fluoro-2′-beta-c-substituted-4′fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection |
ES2907874T3 (es) | 2016-09-07 | 2022-04-26 | Atea Pharmaceuticals Inc | Nucleótidos de purina 2'-sustituidos-N6-sustituidos para el tratamiento de virus de ARN |
WO2018071675A1 (en) * | 2016-10-12 | 2018-04-19 | Georgetown University | Cd99 inhibitors and their uses |
GB201709471D0 (en) | 2017-06-14 | 2017-07-26 | Nucana Biomed Ltd | Diastereoselective synthesis of hosphate derivatives |
GB201715011D0 (en) | 2017-09-18 | 2017-11-01 | Nucana Biomed Ltd | Floxuridine synthesis |
GB201720279D0 (en) | 2017-12-05 | 2018-01-17 | Nucana Biomed Ltd | Anticancer compounds |
GB201904544D0 (en) | 2019-04-01 | 2019-05-15 | NuCana plc | Anticancer compounds |
WO2021173713A1 (en) | 2020-02-27 | 2021-09-02 | Atea Pharmaceuticals, Inc. | Highly active compounds against covid-19 |
US10874687B1 (en) | 2020-02-27 | 2020-12-29 | Atea Pharmaceuticals, Inc. | Highly active compounds against COVID-19 |
CN113549076B (zh) * | 2021-07-23 | 2022-12-06 | 中国药科大学 | 一种多取代嘌呤类化合物及其制备方法和应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR880000094B1 (ko) | 1984-12-07 | 1988-02-23 | 보령제약 주식회사 | 뉴클레오시드 유도체의 제조방법 |
CA2004695C (en) | 1988-12-12 | 1999-08-10 | Rosanne Bonjouklian | Phospholipid nucleosides |
DE4418690A1 (de) * | 1994-05-28 | 1996-01-11 | Boehringer Mannheim Gmbh | Neue Lipidester von Nucleosid-Monophosphaten und deren Verwendung als immunsuppressive Arzneimittel |
GB9505025D0 (en) * | 1995-03-13 | 1995-05-03 | Medical Res Council | Chemical compounds |
DE69534745T2 (de) * | 1995-04-21 | 2006-10-05 | University Of South Florida, Tampa | Immunopotenzierende 5'-nucleotidase-resistente inosinmonophosphat-derivate und ihre verwendung |
JP3761958B2 (ja) | 1996-03-12 | 2006-03-29 | 彰 松田 | 3′−カルバモイルアルキルヌクレオシド誘導体 |
US6245750B1 (en) * | 1998-01-23 | 2001-06-12 | Newbiotics, Inc. | Enzyme catalyzed therapeutic agents |
GB9821058D0 (en) * | 1998-09-28 | 1998-11-18 | Univ Cardiff | Chemical compound |
JP4768909B2 (ja) | 2000-09-29 | 2011-09-07 | 扶桑薬品工業株式会社 | トポイソメラーゼ阻害剤 |
US20030073618A1 (en) | 2001-02-08 | 2003-04-17 | Kozhemyakin Leonid A. | Compounds comprising disulfide-containing peptides and nitrogenous bases, and medical uses thereof |
DE10108851A1 (de) * | 2001-02-23 | 2002-09-12 | Resprotect Gmbh | Verwendung von 5'-substituierten Nukleosiden und/oder deren Prodrugs zur resistenzfreien Therapie von Infektionskrankheiten |
AU2002322325A1 (en) * | 2001-06-22 | 2003-01-08 | Emory University | Beta-2'-or 3'-halonucleosides |
GB0317009D0 (en) | 2003-07-21 | 2003-08-27 | Univ Cardiff | Chemical compounds |
GB0401088D0 (en) | 2004-01-19 | 2004-02-18 | Univ Cardiff | Phosphoramidate derivatives |
EP1773355B1 (en) * | 2004-06-24 | 2014-06-25 | Merck Sharp & Dohme Corp. | Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection |
JP2009504704A (ja) * | 2005-08-15 | 2009-02-05 | エフ.ホフマン−ラ ロシュ アーゲー | 抗ウイルス4′−置換プロヌクレオチドホスホルアミダート |
-
2005
- 2005-03-21 GB GBGB0505781.5A patent/GB0505781D0/en not_active Ceased
-
2006
- 2006-03-16 US US11/886,931 patent/US8263575B2/en active Active
- 2006-03-16 BR BRPI0609704A patent/BRPI0609704B8/pt active IP Right Grant
- 2006-03-16 JP JP2008502453A patent/JP5345381B2/ja not_active Expired - Fee Related
- 2006-03-16 CN CNA200680016708XA patent/CN101175763A/zh active Pending
- 2006-03-16 CA CA2602324A patent/CA2602324C/en active Active
- 2006-03-16 DK DK06710096.6T patent/DK1866324T3/da active
- 2006-03-16 PT PT06710096T patent/PT1866324E/pt unknown
- 2006-03-16 AU AU2006226182A patent/AU2006226182C1/en active Active
- 2006-03-16 PL PL06710096T patent/PL1866324T3/pl unknown
- 2006-03-16 ZA ZA200709011A patent/ZA200709011B/xx unknown
- 2006-03-16 AT AT06710096T patent/ATE471334T1/de active
- 2006-03-16 ES ES06710096T patent/ES2348741T3/es active Active
- 2006-03-16 CN CN201410186829.5A patent/CN103936807A/zh active Pending
- 2006-03-16 EP EP06710096A patent/EP1866324B1/en active Active
- 2006-03-16 WO PCT/GB2006/000932 patent/WO2006100439A1/en active Application Filing
- 2006-03-16 DE DE602006014949T patent/DE602006014949D1/de active Active
- 2006-03-16 SI SI200630762T patent/SI1866324T1/sl unknown
- 2006-03-16 MX MX2007011666A patent/MX2007011666A/es active IP Right Grant
-
2007
- 2007-09-20 IL IL186104A patent/IL186104A/en active IP Right Grant
-
2010
- 2010-09-10 CY CY20101100826T patent/CY1111538T1/el unknown
-
2013
- 2013-05-07 JP JP2013097919A patent/JP5863702B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
BRPI0609704B8 (pt) | 2021-09-28 |
CY1111538T1 (el) | 2015-08-05 |
CA2602324A1 (en) | 2006-09-28 |
CA2602324C (en) | 2015-02-24 |
DK1866324T3 (da) | 2010-09-27 |
ATE471334T1 (de) | 2010-07-15 |
EP1866324A1 (en) | 2007-12-19 |
PT1866324E (pt) | 2010-09-16 |
AU2006226182C1 (en) | 2012-06-14 |
JP2013173786A (ja) | 2013-09-05 |
SI1866324T1 (sl) | 2010-10-29 |
IL186104A (en) | 2013-06-27 |
JP2008533191A (ja) | 2008-08-21 |
GB0505781D0 (en) | 2005-04-27 |
AU2006226182B2 (en) | 2011-09-01 |
AU2006226182A1 (en) | 2006-09-28 |
DE602006014949D1 (de) | 2010-07-29 |
US20090215715A1 (en) | 2009-08-27 |
PL1866324T3 (pl) | 2010-12-31 |
JP5345381B2 (ja) | 2013-11-20 |
CN101175763A (zh) | 2008-05-07 |
MX2007011666A (es) | 2007-11-14 |
BRPI0609704A2 (pt) | 2010-04-20 |
US8263575B2 (en) | 2012-09-11 |
IL186104A0 (en) | 2008-01-20 |
BRPI0609704B1 (pt) | 2020-12-01 |
WO2006100439A1 (en) | 2006-09-28 |
EP1866324B1 (en) | 2010-06-16 |
ES2348741T3 (es) | 2010-12-13 |
CN103936807A (zh) | 2014-07-23 |
JP5863702B2 (ja) | 2016-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200709011B (en) | Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer | |
SG164368A1 (en) | Treatment of cancer | |
MY146112A (en) | Long-term feed - cancer patient | |
MX2009008222A (es) | Antagonistas de activina-actriia y usos para tratar o prevenir cancer de mama. | |
ZA201800056B (en) | Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders | |
TW200612918A (en) | Lonidamine analogs | |
MX2010001821A (es) | Derivados de purina para uso en el tratamiento de enfermedades relacionadas con fap. | |
PH12015500485A1 (en) | Phosphoramidate derivatives of 5 - fluoro - 2` - deoxyuridine for use in the treatment of cancer | |
MX2009010899A (es) | Prediccion de la supervivencia al post-tratamiento en pacientes de cancer con micro-rnas. | |
TW200716141A (en) | Compositions and methods for treatment for neoplasms | |
TW200733166A (en) | Ion sources, systems and methods | |
BRPI0611670A2 (pt) | método para o tratamento ou prevenção de câncer em um indivíduo | |
TW200637522A (en) | Skin treatment articles and methods | |
WO2007064872A3 (en) | Urea compounds useful in the treatment of cancer | |
MX2009009761A (es) | Composiciones y estuches para tratamiento de la influenza. | |
MY147247A (en) | Organic compounds and their uses | |
MX2009012228A (es) | Compuesto de triazolil aminopirimidina. | |
TW200716088A (en) | Formulations and methods for treating amyloidosis | |
WO2009009034A3 (en) | Methods and compositions useful in the treatment of mucositis | |
NO20074780L (no) | Heterocyklylamidsubstituerte imidazoler | |
DE602005015329D1 (de) | Rutheniumkomplexe zur krebsbehandlung | |
EA200971067A1 (ru) | Триазолиламинопиримидиновые соединения | |
WO2009074253A3 (en) | Clofarabine dietherphospholipid derivatives | |
MY166063A (en) | Intravenous antiviral treatments | |
UA101379C2 (en) | Amidophenoxyindazoles useful in the treatment of cancer |